Skip to content

Impact of varying liposomal bupivacaine concentrations in upper brachial plexus nerve blocks on postoperative pain and mobility in patients undergoing shoulder arthroscopy under general anesthesia: a prospective, randomized controlled study

Impact of varying liposomal bupivacaine concentrations in upper brachial plexus nerve blocks on postoperative pain and mobility in patients undergoing shoulder arthroscopy under general anesthesia: a prospective, randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400094688
Enrollment
Unknown
Registered
2024-12-26
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pain

Interventions

66mg bupivacaine liposome group:Upper trunk block of brachial plexus was performed with 66mg bupivacaine liposome
44mg bupivacaine liposome group:Upper trunk block of brachial plexus was performed with 44mg bupivacaine liposome
33mg bupivacaine liposome group:Upper trunk block of brachial plexus was performed with 33mg bupivacaine liposome

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. participants must be 18 years of age or older; 2. participants must be classified as ASA grade I or II; 3. participants must be scheduled for elective arthroscopic rotator cuff repair; 4. participants must demonstrate the ability to adhere to the study protocol and provide informed consent for participation in the clinical trial.

Exclusion criteria

Exclusion criteria: 1. A history of upper limb neuropathy and chronic pain syndrome; 2. An allergy to bupivacaine liposome or a previous history of allergy to local anesthetics; 3. The presence of severe respiratory disease, a history of mental illness, cognitive impairment, or a history of drug or alcohol abuse; 4. Long-term opioid use due to various medical conditions (defined as use for more than three months or a daily intake exceeding 5 mg of morphine for one month); 5. Contraindications to general anesthesia or interscalene brachial plexus block; 6. Pregnancy status.

Design outcomes

Primary

MeasureTime frame
Numeric Rating Scale Score;morphine milligram equivalents (MME);

Secondary

MeasureTime frame
Muscle Balance Scale Score;motor nerve block score;American Shoulder and Elbow Surgeons Score;The Quality of Recovery-15 (QoR-15) score;

Countries

China

Contacts

Public ContactFeng Chen

Shanghai General Hospital

smmuchenfeng@163.com+86 135 6479 1339

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 16, 2026